XML 83 R72.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segments and Disaggregated Revenue (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Segments and Disaggregated Revenue          
Revenue $ 1,253,416 $ 5,097,055 $ 2,271,347 $ 10,600,990  
Cost of revenue 1,094,249 5,063,425 1,739,232 10,636,832  
Operating expenses 2,952,974 5,644,488 7,358,381 8,835,085  
Operating loss (2,793,807) (5,610,858) (6,826,266) (8,870,927)  
Other income (expense) (1,753,963) 55,334 (2,978,532) (204,037)  
Loss before income taxes (4,547,770) (5,555,524) (9,804,798) (9,074,964)  
Common stock deemed dividend (670,881)  
Net income attributable to non-controlling interest 689,077 1,946,822  
Net loss attributable to common stockholders (3,858,693) (5,555,524) (8,528,857) (9,074,964)  
Total assets 20,928,509   20,928,509   $ 17,211,275
Operating Segments [Member]          
Segments and Disaggregated Revenue          
Revenue 1,253,416 5,097,055 2,271,347 10,600,990  
Cost of revenue 1,094,249 5,063,425 1,739,232 10,636,832  
Operating expenses 2,952,974 5,644,488 7,358,381 8,835,085  
Operating loss (2,793,807) (5,610,858) (6,826,266) (8,870,927)  
Other income (expense) (1,753,963) 55,334 (2,978,532) (204,037)  
Loss before income taxes (4,547,770) (5,555,524) (9,804,798) (9,074,964)  
Common stock deemed dividend   (670,881)    
Net income attributable to non-controlling interest 689,077 1,946,822  
Net loss attributable to common stockholders (3,858,693) (5,555,524) (8,528,857) (9,074,964)  
Total assets 20,928,509 5,999,338 20,928,509 5,999,338  
Depreciation and amortization 8,291 562,070 85,034 710,578  
Capital expenditures 7,873  
Operating Segments [Member] | Construction [Member]          
Segments and Disaggregated Revenue          
Revenue 1,211,254 5,097,055 2,179,369 10,600,990  
Cost of revenue 1,094,249 5,063,425 1,739,232 10,636,832  
Operating expenses 91,281 58,428 91,814 176,987  
Operating loss 25,724 (24,798) 348,323 (212,829)  
Other income (expense) (137,955) 233,629 (187,908) 252,193  
Loss before income taxes (112,231) 208,831 160,415 39,364  
Common stock deemed dividend      
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders (112,231) 208,831 160,415 39,364  
Total assets 5,479,525 10,546,140 5,479,525 10,546,140  
Depreciation and amortization 6,484 562,070 81,547 710,578  
Capital expenditures 7,873  
Operating Segments [Member] | Medical [Member]          
Segments and Disaggregated Revenue          
Revenue  
Cost of revenue  
Operating expenses 50,076 85,960 897  
Operating loss (50,076) (85,960) (897)  
Other income (expense)  
Loss before income taxes (50,076) (85,960) (897)  
Common stock deemed dividend      
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders (50,076) (85,960) (897)  
Total assets 1,406 (897) 1,406 (897)  
Depreciation and amortization  
Capital expenditures  
Operating Segments [Member] | Development [Member]          
Segments and Disaggregated Revenue          
Revenue 42,162 91,978  
Cost of revenue  
Operating expenses 945,136 496,463 3,496,628 1,217,376  
Operating loss (902,974) (496,463) (3,404,650) (1,217,376)  
Other income (expense) (1,065,819) (187,749) (1,631,814) (475,046)  
Loss before income taxes (1,968,793) (684,212) (5,036,464) (1,692,422)  
Common stock deemed dividend      
Net income attributable to non-controlling interest 689,077 1,946,822  
Net loss attributable to common stockholders (1,279,716) (684,212) (3,089,642) (1,692,422)  
Total assets 12,654,236 (10,929,782) 12,654,236 (10,929,782)  
Depreciation and amortization  
Capital expenditures  
Operating Segments [Member] | Corporate and support [Member]          
Segments and Disaggregated Revenue          
Revenue  
Cost of revenue  
Operating expenses 1,866,481 5,089,597 3,683,979 7,439,825  
Operating loss (1,866,481) (5,089,597) (3,683,979) (7,439,825)  
Other income (expense) (550,189) 9,454 (1,158,810) 18,816  
Loss before income taxes (2,416,670) (5,080,143) (4,842,789) (7,421,009)  
Common stock deemed dividend   (670,881)    
Net income attributable to non-controlling interest  
Net loss attributable to common stockholders (2,416,670) (5,080,143) (5,513,670) (7,421,009)  
Total assets 2,793,342 6,383,877 2,793,342 6,383,877  
Depreciation and amortization 1,807 3,487  
Capital expenditures